Correction to: Population pharmacokinetic and exploratory exposure –response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study

Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research